Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Doubts Over China's First Alzheimer's Drug Resurface Amid Research Miscount Allegation
Speed Over Quality?
Jul 09 2020
•
By
Brian Yang
LEADING RESEARCHER QUESTIONS CHINA AD DRUG GV971 - 'IMPOSSIBLE WITHOUT FABRICATION' • Source: Shutterstock
More from China
More from Focus On Asia